ArticleOncotarget2016

Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.

Nameeta P Richard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.